Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF-β/SMAD signaling.
Zhirui ZhangWei WuHao JiaoYuzhong ChenXiaojun JiJing CaoFangzhou YinKaiyong YangPublished in: British journal of pharmacology (2022)
Taken together, SQLE serves as a novel oncogene in HCC development by activating TGF-β/SMAD signaling, and targeting SQLE could be useful in drug development and therapy for HCC.